A post hoc analysis shows significantly improved ORR and PFS in advanced NSCLC with higher AFM24 exposure, supporting ...

Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomas.

The immune system is comprised of two separate active arms of immunity to provide robust protection against disease. The two separate systems of immunity i | Immunology ...

Mammary gland fibroblasts are highly plastic and transition through distinct states during development and disease. A new ...

Scientists have developed a new, ready-made way to fight acute myeloid leukemia and other blood cancers that looks promising.

ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...

Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune ...

Unlike other cancers that have a mass or tumor doctors can remove for treatment, Leukemia, that affect a person's blood, ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.

CAR NK-cell therapy prompted remission in 4 out of 9 patients, and a substantial response in a fifth The therapy can be made ...